Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of Novartis's Atrasentan hydrochloride?
Atrasentan hydrochloride is a small molecule commercialized by Novartis, with a leading Pre-Registration program in IgA Nephropathy (Berger's Disease). According...
Data Insights
Risk adjusted net present value: What is the current valuation of Novartis's Atrasentan hydrochloride?
Atrasentan hydrochloride is a small molecule commercialized by Novartis, with a leading Phase III program in IgA Nephropathy (Berger's Disease)....